Search Results 1-10 of 17016 for Humira

  1. A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Mayo Clinic

    A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) · More about research at Mayo Clinic · Mayo ...

  2. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Brand Name. US Brand Name. ABRILADA. Amjevita. Cyltezo. Hadlima. Hulio. Humira. Hyrimoz. Idacio. Simlandi. Yuflyma. Yusimry. Back to top. Description.

  3. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease.

  4. Adalimumab-aqvh (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aqvh injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  5. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

    Adalimumab-adaz injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  6. Adalimumab-aacf (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aacf injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  7. Adalimumab-afzb (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-afzb injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  8. Adalimumab-ryvk (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-ryvk injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis. It is used in children 2 years ...

  9. Adalimumab-aaty (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aaty injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  10. Adalimumab-adbm (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-adbm injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...